Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.

Area of Science:

• Oncology
• Dermatology
• Molecular Biology

Background:

• Cutaneous melanoma is linked to ultraviolet radiation (UVR), but the precise molecular mechanisms are unclear.
• The BRAF V600E mutation is a common early event in melanoma development.
• The role of TP53 mutations in UVR-driven melanoma is not well understood.

Purpose of the Study:

• To investigate how UVR accelerates oncogenic BRAF-driven melanomagenesis.
• To determine the role of Trp53 mutations in UVR-induced melanoma in a mouse model.
• To explore the link between UVR-induced DNA damage and TP53 mutations in human melanoma.

Main Methods:

• Utilized a BRAF(V600E) mouse model to study melanomagenesis.
• Administered single and repeated doses of UVR to mice.
• Analyzed UVR-exposed tumors for mutations, including in the Trp53 tumor suppressor gene.
• Investigated the effect of mutant Trp53 on BRAF(V600E)-driven melanomagenesis in mice.

Main Results:

• Single-dose UVR induced melanocyte clonal expansion; repeated doses increased melanoma burden.
• Sunscreen (SPF 50) provided only partial protection against UVR-driven melanoma.
• Approximately 40% of UVR-exposed tumors in mice had Trp53 mutations.
• Mutant Trp53 significantly accelerated BRAF(V600E)-driven melanomagenesis in mice.
• TP53 mutations in human melanoma correlated with evidence of UVR-induced DNA damage.

Conclusions:

• TP53/Trp53 acts as a UVR-target gene that cooperates with BRAF(V600E) to accelerate melanoma development.
• This study provides mechanistic insight into the epidemiological link between UVR and melanoma.
• Findings support public health campaigns promoting sunscreen use for melanoma prevention.